Literature DB >> 22057702

Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature.

Ella M Meumann1, Allen C Cheng, Linda Ward, Bart J Currie.   

Abstract

BACKGROUND: Melioidosis is an important cause of community-acquired sepsis in Southeast Asia and northern Australia, and pneumonia is the most common presentation. Clinical manifestations range from acute fulminant sepsis to chronic infection mimicking tuberculosis. Pneumonia may be the primary presenting feature, or it can develop secondary to initial disease at a distant focus.
METHODS: A prospective database of all melioidosis patients at Royal Darwin Hospital (Australia) between 1989 and 2010 was reviewed.
RESULTS: Of 624 patients with culture-confirmed melioidosis, 319 (51%) presented with pneumonia as the primary diagnosis. Acute/subacute presentations accounted for the majority of primary pneumonia cases (91%); chronic disease was seen less commonly (9%). Secondary pneumonia developed in 20% of patients with other primary melioidosis presentations and was particularly common in those with positive blood cultures. Risk factors for presentation with primary pneumonia (compared with other primary presentations) were rheumatic heart disease or congestive cardiac failure, chronic obstructive pulmonary disease, smoking, and diabetes mellitus, with P < .05 for these conditions in a multivariate logistic regression model. Patients presenting with pneumonia more frequently developed septic shock (33% vs 10%; P < .001) and died (20% vs 8%; P <.001) compared with patients with other primary presentations. Multilobar disease occurred in 28% of primary pneumonia patients and was associated with greater mortality (32%) than in those with single-lobe disease (14%; P < .001).
CONCLUSIONS: Melioidosis pneumonia is often a rapidly progressive illness with high mortality, particularly among those with multilobar disease. Risk factors have been identified, and early diagnosis and treatment should be priorities.

Entities:  

Mesh:

Year:  2011        PMID: 22057702      PMCID: PMC3258273          DOI: 10.1093/cid/cir808

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Value of throat swab in diagnosis of melioidosis.

Authors:  V Wuthiekanun; Y Suputtamongkol; A J Simpson; P Kanaphun; N J White
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team.

Authors:  J P Nuorti; J C Butler; M M Farley; L H Harrison; A McGeer; M S Kolczak; R F Breiman
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

3.  Pulmonary melioidosis; a diagnostic dilemma and increasing threat.

Authors:  R J Flemma; F C DiVincenti; L N Dotin; B A Pruitt
Journal:  Ann Thorac Surg       Date:  1969-06       Impact factor: 4.330

4.  Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group.

Authors:  B M Farr; C L Bartlett; J Wadsworth; D L Miller
Journal:  Respir Med       Date:  2000-10       Impact factor: 3.415

Review 5.  Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature.

Authors:  B J Currie; D A Fisher; D M Howard; J N Burrow; D Lo; S Selva-Nayagam; N M Anstey; S E Huffam; P L Snelling; P J Marks; D P Stephens; G D Lum; S P Jacups; V L Krause
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

6.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

Review 7.  Melioidosis.

Authors:  N J White
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

8.  Bacteraemic melioidosis pneumonia: impact on outcome, clinical and radiological features.

Authors:  Amartya Mukhopadhyay; Kang Hoe Lee; Paul Ananth Tambyah
Journal:  J Infect       Date:  2004-05       Impact factor: 6.072

9.  Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis.

Authors:  M R O'Carroll; T J Kidd; C Coulter; H V Smith; B R Rose; C Harbour; S C Bell
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

10.  Intensity of rainfall and severity of melioidosis, Australia.

Authors:  Bart J Currie; Susan P Jacups
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

View more
  56 in total

1.  Role of Toll-Like Receptor 5 (TLR5) in Experimental Melioidosis.

Authors:  Emma Birnie; Tassili A F Weehuizen; Jacqueline M Lankelma; Hanna K de Jong; Gavin C K W Koh; Miriam H P van Lieshout; Joris J T H Roelofs; Andries E Budding; Alex F de Vos; Tom van der Poll; W Joost Wiersinga
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  Osteomyelitis and septic arthritis from infection with Burkholderia pseudomallei: A 20-year prospective melioidosis study from northern Australia.

Authors:  Levi P Morse; Jonathan Smith; Janak Mehta; Linda Ward; Allen C Cheng; Bart J Currie
Journal:  J Orthop       Date:  2013-05-13

3.  Melioidosis presenting as Fever and jaundice: a rare presentation.

Authors:  Pankaj Tyagi; Vinit Shah; Praveen Sharma; Naresh Bansal; Vikas Singla; Ashish Kumar; Anil Arora
Journal:  J Clin Exp Hepatol       Date:  2013-10-25

4.  Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.

Authors:  Andrew E Scott; Mary N Burtnick; Margaret G M Stokes; Adam O Whelan; E Diane Williamson; Timothy P Atkins; Joann L Prior; Paul J Brett
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

5.  Revised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Christian Heiss; Mary N Burtnick; Rosemary A Roberts; Ian Black; Parastoo Azadi; Paul J Brett
Journal:  Carbohydr Res       Date:  2013-08-24       Impact factor: 2.104

6.  Involvement of L-selectin expression in Burkholderia pseudomallei-infected monocytes invading the brain during murine melioidosis.

Authors:  Yao-Shen Chen; Hsi-Hsun Lin; Pei-Tan Hsueh; Wei-Fen Ni; Pei-Ju Liu; Pei-Shih Chen; Hsin-Hou Chang; Der-Shan Sun; Ya-Lei Chen
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

7.  Morphological Alteration and Survival of Burkholderia pseudomallei in Soil Microcosms.

Authors:  Watcharaporn Kamjumphol; Pisit Chareonsudjai; Suwimol Taweechaisupapong; Sorujsiri Chareonsudjai
Journal:  Am J Trop Med Hyg       Date:  2015-08-31       Impact factor: 2.345

Review 8.  Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory.

Authors:  Peera Hemarajata; Jonathan D Baghdadi; Risa Hoffman; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2016-09-21       Impact factor: 5.948

9.  A case report of melioidosis in a diabetic patient in a union territory.

Authors:  Esther Paul; M Sudhagar; S Anandhalakshmi; Shanthi Mathias
Journal:  Australas Med J       Date:  2013-08-31

10.  Global burden of melioidosis in 2015: a systematic review and data synthesis.

Authors:  Emma Birnie; Harjeet S Virk; Jelmer Savelkoel; Rene Spijker; Eric Bertherat; David A B Dance; Direk Limmathurotsakul; Brecht Devleesschauwer; Juanita A Haagsma; W Joost Wiersinga
Journal:  Lancet Infect Dis       Date:  2019-07-05       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.